Javascript must be enabled to continue!
Deep-mining the antibody repertoires of transgenic mouse models with high-throughput single cell BCR and whole transcriptome sequencing 3955
View through CrossRef
Abstract Description
Transgenic mouse models are excellent tools to model human antibody response against antigens of choice, given their ability to undergo diversification, in vivo affinity maturation, clonal selection and clonal expansion in their natural immune environment. Current antibody discovery methods lack the scale required to fully screen the antibody repertoire of transgenic mouse models to uncover the maximum number of desirable antibody hits per discovery campaign. Here, we demonstrate our novel combinatorial barcoding approach to enable high-throughput single cell BCR and whole transcriptome profiling of transgenic mouse samples with unprecedented sensitivity, scalability, and flexibility. As a proof of concept, we profiled over 1 million cells from multiple transgenic mice that were either naive or immunized with antigens of interest to obtain hundreds of thousands of paired BCR clonotypes. Using the whole transcriptome data we detected all B cell subpopulations including plasma cells at single cell resolution. We then used the paired heavy and light chain BCR data to detect productive chains in the majority of B cells revealing both unique and expanded clonotypes. In the expanded clonotype pool we found specific patterns of VDJ utilization and amino acid motifs compared to the naive pool. This method paves the way for high throughput screening of antibody repertoires from transgenic mice to allow for deep mining of antibodies.
Topic Categories
Technological Innovations in Immunology (TECH)
Oxford University Press (OUP)
Title: Deep-mining the antibody repertoires of transgenic mouse models with high-throughput single cell BCR and whole transcriptome sequencing 3955
Description:
Abstract Description
Transgenic mouse models are excellent tools to model human antibody response against antigens of choice, given their ability to undergo diversification, in vivo affinity maturation, clonal selection and clonal expansion in their natural immune environment.
Current antibody discovery methods lack the scale required to fully screen the antibody repertoire of transgenic mouse models to uncover the maximum number of desirable antibody hits per discovery campaign.
Here, we demonstrate our novel combinatorial barcoding approach to enable high-throughput single cell BCR and whole transcriptome profiling of transgenic mouse samples with unprecedented sensitivity, scalability, and flexibility.
As a proof of concept, we profiled over 1 million cells from multiple transgenic mice that were either naive or immunized with antigens of interest to obtain hundreds of thousands of paired BCR clonotypes.
Using the whole transcriptome data we detected all B cell subpopulations including plasma cells at single cell resolution.
We then used the paired heavy and light chain BCR data to detect productive chains in the majority of B cells revealing both unique and expanded clonotypes.
In the expanded clonotype pool we found specific patterns of VDJ utilization and amino acid motifs compared to the naive pool.
This method paves the way for high throughput screening of antibody repertoires from transgenic mice to allow for deep mining of antibodies.
Topic Categories
Technological Innovations in Immunology (TECH).
Related Results
Abstract 5662: Deep-mining the antibody repertoires of transgenic mouse models with high-throughput single cell BCR and whole transcriptome sequencing
Abstract 5662: Deep-mining the antibody repertoires of transgenic mouse models with high-throughput single cell BCR and whole transcriptome sequencing
Abstract
Transgenic mouse models are excellent tools to model human antibody response against antigens or disease of choice, given their ability to undergo diversifi...
PARP Inhibition Sensitize BCR-ABL1 Positive Cel
PARP Inhibition Sensitize BCR-ABL1 Positive Cel
Introduction:
BCR-ABL1 play a key role in the development of chronic myelogenous leukemia and a part of Ph1 positive acute lymphoblastic leukemia (ALL). BCR-ABL1 fun...
TRIM28 Facilitates Chronic Myeloid Leukemia Progression By Enhancing Sumoylation and Stability of BCR-ABL
TRIM28 Facilitates Chronic Myeloid Leukemia Progression By Enhancing Sumoylation and Stability of BCR-ABL
Chronic myeloid leukemia (CML) is a hematopoietic malignancy caused by the BCR-ABL fusion gene. Although tyrosine kinase inhibitors (TKIs) targeting the oncoprotein BCR-ABL have dr...
Development and reproduction of Tetranychus cinnabarinus (Acari: Tetranychiae) on transgenic insect-resistant cotton plants
Development and reproduction of Tetranychus cinnabarinus (Acari: Tetranychiae) on transgenic insect-resistant cotton plants
The effects of two insect-resistant transgenic cotton strains (transgenic Bt pest-resistant cotton Zhongkangza 5 and Lumianyan 23, transgenic Bt+CpTI pest-resistant cotton sGK958 a...
Molecular Predictors for the Response to Nilotinib Treatment After Acquired Imatinib Failure In Ph+ Chronic Myeloid Leukemia
Molecular Predictors for the Response to Nilotinib Treatment After Acquired Imatinib Failure In Ph+ Chronic Myeloid Leukemia
Abstract
Abstract 2283
Introduction:
A switch to the 2nd generation tyrosine kinase inhibitor nilotinib has been ...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
e0061 The modulation of dilated cardiomyopathy by Hepc1 in cTnTR141W transgenic mice
e0061 The modulation of dilated cardiomyopathy by Hepc1 in cTnTR141W transgenic mice
Objective
Iron regulatory hormone hepcidin is possible to be possibly involved in the physiological function of heart and pathogenesis of heart disease. The curre...
Detection of Compound BCR-ABL Mutations in TKI Resistant CML Patients Including a Novel K245N Mutation Associated with Primary Nilotinib Resistance By Employing a Newly Developed Cost Effective BCR-ABL Sequencing Protocol
Detection of Compound BCR-ABL Mutations in TKI Resistant CML Patients Including a Novel K245N Mutation Associated with Primary Nilotinib Resistance By Employing a Newly Developed Cost Effective BCR-ABL Sequencing Protocol
Abstract
Introduction: BCR-ABL mutations are the major background players in manifestation of resistance to all FDA approved tyrosine kinase inhibitors (TKIs) includ...

